Article
Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
2016-07-23
Abstract excerpt
Pharmacogenetics (PGx) has the potential to personalize pharmaceutical treatments. Many relevant gene-drug associations have been discovered, but PGx guided treatment needs to be cost-effective as well as clinically beneficial to be incorporated into standard healthcare. Progress in this area can be assessed by reviewing economic evaluations to determine the cost-effectiveness of PGx testing versus standard treatm...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 79ef130e-d637-5aef-9505-3ad7db4fa38d
- DOI
- 10.1101/065540